Yorioka N - Search Results

1

Plasma thrombomodulin: usefulness as a blood access failure marker in hemodialysis patients.

Taniguchi Y, Yorioka N, Oda H, Masaki T, Usui K, Harada S, Yamakido M. Taniguchi Y, et al. Among authors: yorioka n. Nephron. 1996;73(1):91-3. doi: 10.1159/000189007. Nephron. 1996. PMID: 8742964 Clinical Trial.

2

Continuous ambulatory peritoneal dialysis is superior to hemodialysis in chronic dialysis patients with cerebral hemorrhage.

Yorioka N, Oda H, Ogawa T, Taniguchi Y, Kushihata S, Takemasa A, Usui K, Shigemoto K, Harada S, Yamakido M. Yorioka N, et al. Nephron. 1994;67(3):365-6. doi: 10.1159/000187998. Nephron. 1994. PMID: 7936034 Free article. No abstract available.

3

Renal osteodystrophy in hemodialysis patients.

Oda H, Yorioka N, Takemasa A, Shigemoto K, Harada S, Ito T, Masaki T, Yamakido M. Oda H, et al. Among authors: yorioka n. Hiroshima J Med Sci. 1995 Sep;44(3):83-8. Hiroshima J Med Sci. 1995. PMID: 8567317

4

Platelet-derived growth factor, interleukin (IL)-1 beta, IL-6R and tumor necrosis factor-alpha in IgA nephropathy. An immunohistochemical study.

Taniguchi Y, Yorioka N, Oda H, Yamakido M. Taniguchi Y, et al. Among authors: yorioka n. Nephron. 1996;74(4):652-60. doi: 10.1159/000189470. Nephron. 1996. PMID: 8956297

5

Remnant-like particle cholesterol may indicate atherogenic risk in patients on chronic hemodialysis.

Oda H, Yorioka N, Okushin S, Nishida Y, Kushihata S, Ito T, Yamakido M. Oda H, et al. Among authors: yorioka n. Nephron. 1997;76(1):7-14. doi: 10.1159/000190133. Nephron. 1997. PMID: 9171293

6

Hypercoagulability and secondary hyperfibrinolysis may be related to abnormal lipid metabolism in patients treated with continuous ambulatory peritoneal dialysis.

Kobayashi M, Yorioka N, Yamakido M. Kobayashi M, et al. Among authors: yorioka n. Nephron. 1997;76(1):56-61. doi: 10.1159/000190141. Nephron. 1997. PMID: 9171301

7

Interleukin-6 localization and the prognosis of IgA nephropathy.

Taniguchi Y, Yorioka N, Kumagai J, Katsutani M, Kuratsune M, Amimoto D, Yamakido M. Taniguchi Y, et al. Among authors: yorioka n. Nephron. 1999 Jan;81(1):94-8. doi: 10.1159/000045254. Nephron. 1999. PMID: 9884428 Clinical Trial.

8

Transforming growth factor-beta1 may be involved in shunt obstruction in patients on chronic hemodialysis.

Taniguchi Y, Yorioka N, Yamashita K, Masaki T, Yamakido M. Taniguchi Y, et al. Among authors: yorioka n. Nephron. 1999 Jan;81(1):102-5. doi: 10.1159/000045256. Nephron. 1999. PMID: 9884430 Clinical Trial.

9

Tissue factor and tissue factor pathway inhibitor in hemodialysis patients.

Yorioka N, Taniguchi Y, Yamashita K, Ueda C, Nakamura C, Harada S, Yamakido M. Yorioka N, et al. Int J Artif Organs. 1998 Nov;21(11):699-701. Int J Artif Organs. 1998. PMID: 9894744

10

Factors influencing arteriovenous fistula dysfunction in Japanese patients on chronic hemodialysis.

Masaki T, Yorioka N, Kyuden Y, Yamashita K, Taniguchi Y, Yamakido M, Tanaka J, Harada S. Masaki T, et al. Among authors: yorioka n. Int J Artif Organs. 1999 Jan;22(1):14-7. Int J Artif Organs. 1999. PMID: 10098579

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters